You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

avastin failure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

End Stage Renal Disease, Hemodialysis Vascular Access Failure Trial (1.25mg bevacizumab, 2.50mg bevacizumab)

Withdrawn
  • End Stage Renal Disease
  • Hemodialysis Vascular Access Failure
  • 1.25mg bevacizumab
  • 2.50mg bevacizumab
  • (no location specified)
Jul 6, 2020

Corneal Neovascularization, Corneal Graft Failure Trial in Miami, Boston, New York (Avastin® (bevacizumab), 0.9% NaCl & Refresh

Completed
Has Results
  • Corneal Neovascularization
  • Corneal Graft Failure
  • Avastin® (bevacizumab)
  • 0.9% NaCl & Refresh Liquigel
  • Miami, Florida
  • +2 more
Aug 6, 2020

NSCLC Stage IV Trial in Worldwide (Bevacizumab as MYL-1402O, Bevacizumab as Avastin)

Completed
Has Results
  • NSCLC Stage IV
  • Bevacizumab as MYL-1402O
  • Bevacizumab as Avastin
  • Grodno, Hrodzenskaya Voblasts, Belarus
  • +101 more
Mar 15, 2022

NSCLC Trial in Worldwide (FKB238 (bevacizumab), Avastin (bevacizumab), Paclitaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • FKB238 (bevacizumab)
  • +3 more
  • Fountain Valley, California
  • +146 more
Feb 25, 2022

Glioblastoma Trial in Boston, San Antonio (Bevacizumab, TH-302)

Completed
Has Results
  • Glioblastoma
  • Boston, Massachusetts
  • +1 more
Apr 9, 2020

Recurrent Glioblastoma Trial in Miami (Intensity Modulated Proton Therapy (IMPT), Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • Miami, Florida
    University of Miami
Sep 30, 2022

Ovarian Cancer Trial in Worldwide (Bevacizumab, liposomal doxorubicin, paclitaxel)

Completed
Has Results
  • Ovarian Cancer
  • Bruxelles, Belgium
  • +116 more
May 5, 2022

EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Trial in Worldwide (Atezolizumab, Bevacizumab, Carboplatin)

Active, not recruiting
  • EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
  • Großhansdorf, Germany
  • +17 more
Jan 12, 2023

NSCLC Trial in Worldwide (MB02 (Bevacizumab Biosimilar Drug), EU-approved Avastin®, Carboplatin)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • MB02 (Bevacizumab Biosimilar Drug)
  • +3 more
  • Maceió, AL, Brazil
  • +117 more
Mar 26, 2021

Glaucoma Trial in London (bevacizumab, 5-fluorouracil, Dexamethasone)

Completed
  • Glaucoma
  • London, United Kingdom
    Moorfields Eye Hospital, Clinical Research Facility
Aug 16, 2021

Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Washington (Atezolizumab, Bevacizumab)

Not yet recruiting
  • Colon Adenocarcinoma
  • +6 more
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jul 28, 2022

Healthy Male Subjects Trial in Changchun (HLX04, US-Avastin®, EU-Avastin®)

Completed
  • Healthy Male Subjects
  • Changchun, Jilin, China
    The First Hospital of Jilin University
May 6, 2022

NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Arkhangel'sk, Russian Federation
  • +10 more
Dec 8, 2022

Radiation Necrosis Trial in Lexington, Louisville (25% Mannitol, Low-dose Intra-arterial Bevacizumab)

Completed
Has Results
  • Radiation Necrosis
  • 25% Mannitol
  • Low-dose Intra-arterial Bevacizumab
  • Lexington, Kentucky
  • +1 more
May 2, 2022

Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)

Completed
  • Metastatic Breast Cancer
  • Chuo-ku, Nihonbashi, Koami-cho, Tokyo, Japan
    Japan Breast Cancer Research Group
Aug 2, 2022

NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Brain Neoplasms
  • (no location specified)
Dec 9, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Rectal Cancer, Lung Cancer, Ovarian Cancer Trial in Changchun (Bevacizumab injection, Bevacizumab injection(Avastin))

Completed
  • Rectal Cancer
  • +4 more
  • Bevacizumab injection
  • Bevacizumab injection（Avastin）
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Jul 25, 2022

Age-Related Macular Degeneration Trial in Worldwide (E10030, bevacizumab or aflibercept, E10030 sham injection)

Terminated
Has Results
  • Age-Related Macular Degeneration
  • Gilbert, Arizona
  • +206 more
Sep 29, 2020

Metastatic Colorectal Cancer Trial in Beijing (Bevacizumab, Capecitabine, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Bevacizumab
  • +4 more
  • Beijing, China
    Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Mar 9, 2022

Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial in Seoul (Oregovomab, Bevacizumab,

Recruiting
  • Ovarian Cancer by FIGO Stage
  • +2 more
  • Oregovomab
  • +3 more
  • Daegu, Korea, Republic of
  • +5 more
Oct 20, 2022

Diabetic Macular Edema Trial (Bevacizumab Injection [Avastin] (IVB-I), Triamcinolone Acetonide 10mg/mL (IVT-II), Bevacizumab

Completed
  • Diabetic Macular Edema
  • Bevacizumab Injection [Avastin] (IVB-I)
  • +2 more
  • (no location specified)
May 24, 2022

Macular Degeneration Trial (Zimura, Avastin, Lucentis)

Completed
  • Macular Degeneration
  • (no location specified)
Oct 4, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,

Recruiting
  • Glioblastoma
  • +3 more
  • Radiation: Intra-operative Radiation Therapy - IORT
  • +2 more
  • Santa Monica, California
    Providence Saint John's Health Center
Jul 14, 2022

NSCLC Stage IIIB, NSCLC Stage IV, EGFR Activating Mutation Trial in Hong Kong (Atezolizumab, Bevacizumab, Carboplatin)

Unknown status
  • NSCLC Stage IIIB
  • +2 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Apr 16, 2019